Quan Liu Retweeted CGTN America
Great. Accessibility and affordability.https://twitter.com/cgtnamerica/status/1302662077807570945 …
Quan Liu added,
1:38
CGTN AmericaVerified account @cgtnamerica
The COVID-19 vaccine produced by China's Sinovac Biotech has entered phase 3 trial globally. Helen Yang from the company says the clinical trial will be completed by the end of the year and the vaccine will be available soon in the market at an affordable price after approval. pic.twitter.com/63pDWLLjoe
11:01 AM - 6 Sep 2020
1 reply
2 retweets
5 likes
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.